Jemma Arakelyan has been selected as the CEO of the Institute of Cancer and Crisis
It is a pleasure to announce that Jemma Arakelyan, a board member of the Institute of Cancer and Crisis (ICC), has been selected as the Institute’s Chief Executive Officer (CEO).
Dr. Jemma Arakelyan is a medical oncologist and Ph.D. candidate at the City University of Hong Kong.
She is an alumna of Yerevan State Medical University and Harvard Medical School. Her research focuses on developing new anticancer treatments and understanding the underlying mechanisms of cancer progression.
In addition to her academic pursuits, she is an active member of several scientific organizations, including the European School of Oncology (ESO), where she served as an ambassador in Armenia from 2020-2022.
We hope our institute will reach new achievements under her strong leadership
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023